Tevogen Bio Holdings (TVGN) Total Liabilities (2021 - 2026)

Tevogen Bio Holdings has reported Total Liabilities for 6 years, with the latest figure at $14.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities rose 25.18% year-over-year to $14.8 million; the trailing twelve-month figure through Mar 2026 stood at $14.8 million (up 25.18% YoY), and the FY2025 full-year result was $12.6 million, up 24.49% from the prior year.
• Total Liabilities for Q1 2026 stood at $14.8 million, up from $12.6 million in the prior quarter.
• The five-year high for Total Liabilities was $99.9 million in Q4 2023, with the low at $9.2 million in Q1 2024.
• Historically, Total Liabilities has averaged $18.5 million across 5 years, with a median of $14.8 million in 2026.
• Annual changes were most pronounced in 2023 — Total Liabilities soared 563.68% — and 2024, when it plunged 89.86%.
• Tevogen Bio Holdings' Total Liabilities stood at $15.1 million in 2022, then soared by 563.68% to $99.9 million in 2023, then sank by 89.86% to $10.1 million in 2024, then rose by 24.49% to $12.6 million in 2025, then climbed by 17.0% to $14.8 million in 2026.
• The last three Total Liabilities figures came in at $14.8 million (Q1 2026), $12.6 million (Q4 2025), and $12.3 million (Q3 2025), per Business Quant data.